TDP1 and neoplasm: Indeed, it was found that combined treatment of tumor cells with Tdp1 inhibitors and anticancer drugs camptothecin or topotecan greatly increased the activity of these pharmaceuticals in in vitro [21,22,23,24,25,26,27,28] and in vivo [29,30] experiments.